Market Cap (In TWD)
6.17 Billion
Revenue (In TWD)
1.05 Billion
Net Income (In TWD)
30.03 Million
Avg. Volume
2.63 Million
- Currency
- TWD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 18.1-27.8
- PE
- -
- EPS
- -
- Beta Value
- 0.53
- ISIN
- TW0004167002
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Chih-Fang Chen
- Employee Count
- -
- Website
- https://www.saviorlifetec.com.tw/en/
- Ipo Date
- 2012-12-21
- Details
- Savior Lifetec Corporation, a specialty injectable company, produces and supplies sterile APIs and finished dosage formulations. The company offers imipenem and cilastatin sodium, an antibacterial agent for intravenous infusion; and meropenem, a beta-lactamase resistant carbapenem antibiotic for parenteral administration. It also provides ertapenem, a form of carbapenem for use on gram-negative and gram-positive anaerobes and aerobic. The company's pipeline products include SLC-006 for prostate cancer endometriosis uterine leiomyoma; and sterile paliperidone palmitate API for the treatment of schizophrenia. Savior Lifetec Corporation was founded in 2004 and is headquartered in Miaoli County, Taiwan.
More Stocks
-
PKCOFPARK24 Co., Ltd.
PKCOF
-
216050Incross Co., Ltd.
216050
-
6573
-
002380KCC Corporation
002380
-
008730Youlchon Chemical Co.,Ltd.
008730
-
PXMFF
-
000050Kyungbangco.Ltd
000050
-
009290